Collectively, these results underscore the importance of these genes in the pathophysiology of HNSCC and LSCC, with LAMC2 and PLAU standing out as particularly promising targets for further research and potential therapeutic intervention. This evidence concerns the gene PLAU and head and neck squamous cell carcinoma.